Intuitive Surgical, Inc. $ISRG Holdings Cut by Vestmark Advisory Solutions Inc.

Vestmark Advisory Solutions Inc. lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 34.9% in the second quarter, HoldingsChannel reports. The institutional investor owned 11,165 shares of the medical equipment provider’s stock after selling 5,979 shares during the period. Vestmark Advisory Solutions Inc.’s holdings in Intuitive Surgical were worth $6,067,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of the stock. TD Capital Management LLC boosted its position in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after purchasing an additional 45 shares during the last quarter. 1248 Management LLC acquired a new position in Intuitive Surgical in the 1st quarter worth about $30,000. Princeton Global Asset Management LLC purchased a new stake in shares of Intuitive Surgical during the 2nd quarter worth about $30,000. Bank of Jackson Hole Trust lifted its holdings in shares of Intuitive Surgical by 70.5% during the 1st quarter. Bank of Jackson Hole Trust now owns 75 shares of the medical equipment provider’s stock valued at $37,000 after buying an additional 31 shares during the last quarter. Finally, CBIZ Investment Advisory Services LLC lifted its holdings in shares of Intuitive Surgical by 49.1% during the 1st quarter. CBIZ Investment Advisory Services LLC now owns 82 shares of the medical equipment provider’s stock valued at $41,000 after buying an additional 27 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

ISRG stock opened at $560.00 on Friday. The stock has a market capitalization of $200.75 billion, a price-to-earnings ratio of 74.07, a price-to-earnings-growth ratio of 4.94 and a beta of 1.62. The company has a 50-day moving average of $471.89 and a two-hundred day moving average of $500.87. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm’s revenue was up 22.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.84 EPS. Equities analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, EVP Myriam Curet sold 125 shares of the stock in a transaction dated Wednesday, October 29th. The shares were sold at an average price of $543.00, for a total value of $67,875.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO David J. Rosa sold 24,500 shares of Intuitive Surgical stock in a transaction dated Friday, October 24th. The stock was sold at an average price of $547.55, for a total value of $13,414,975.00. Following the sale, the chief executive officer directly owned 234,256 shares in the company, valued at approximately $128,266,872.80. This trade represents a 9.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 98,078 shares of company stock valued at $51,445,892 in the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of research firms recently commented on ISRG. Daiwa Capital Markets increased their price objective on Intuitive Surgical from $510.00 to $550.00 and gave the stock an “outperform” rating in a report on Friday, October 24th. HSBC boosted their target price on shares of Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Royal Bank Of Canada set a $625.00 price target on shares of Intuitive Surgical and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research note on Friday, October 31st. Finally, The Goldman Sachs Group upped their price objective on shares of Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $608.92.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.